SG11201500234YA - Process for making isoquinoline compounds - Google Patents
Process for making isoquinoline compoundsInfo
- Publication number
- SG11201500234YA SG11201500234YA SG11201500234YA SG11201500234YA SG11201500234YA SG 11201500234Y A SG11201500234Y A SG 11201500234YA SG 11201500234Y A SG11201500234Y A SG 11201500234YA SG 11201500234Y A SG11201500234Y A SG 11201500234YA SG 11201500234Y A SG11201500234Y A SG 11201500234YA
- Authority
- SG
- Singapore
- Prior art keywords
- isoquinoline compounds
- making
- making isoquinoline
- compounds
- isoquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261672191P | 2012-07-16 | 2012-07-16 | |
PCT/US2013/050538 WO2014014834A1 (en) | 2012-07-16 | 2013-07-15 | Process for making isoquinoline compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201500234YA true SG11201500234YA (en) | 2015-02-27 |
Family
ID=48857024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201500234YA SG11201500234YA (en) | 2012-07-16 | 2013-07-15 | Process for making isoquinoline compounds |
Country Status (21)
Country | Link |
---|---|
US (2) | US9340511B2 (en) |
EP (2) | EP3219706A1 (en) |
JP (1) | JP6196671B2 (en) |
KR (1) | KR102145272B1 (en) |
CN (2) | CN103435546B (en) |
AU (1) | AU2013290437B2 (en) |
BR (1) | BR112015001106B1 (en) |
CA (1) | CA2879238C (en) |
DK (1) | DK2872487T3 (en) |
ES (1) | ES2631655T3 (en) |
HU (2) | HUE034409T2 (en) |
IL (1) | IL236625B (en) |
IN (1) | IN2015KN00265A (en) |
MX (1) | MX350922B (en) |
MY (1) | MY171483A (en) |
NZ (1) | NZ704660A (en) |
PL (1) | PL2872487T3 (en) |
PT (1) | PT2872487T (en) |
SG (1) | SG11201500234YA (en) |
WO (1) | WO2014014834A1 (en) |
ZA (1) | ZA201500664B (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102977015B (en) | 2003-06-06 | 2015-05-06 | 菲布罗根有限公司 | Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
CN107540607A (en) * | 2012-07-16 | 2018-01-05 | 菲布罗根有限公司 | The crystal habit of prolyl hydroxylase inhibitors |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
MY171483A (en) | 2012-07-16 | 2019-10-15 | Fibrogen Inc | Process for making isoquinoline compounds |
KR20220164069A (en) | 2013-06-06 | 2022-12-12 | 피브로겐, 인크. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
CN103694172A (en) * | 2013-12-26 | 2014-04-02 | 辽宁亿灵科创生物医药科技有限公司 | Derivative of aza-aryl compound |
CN105384687B (en) | 2014-09-02 | 2018-05-01 | 广东东阳光药业有限公司 | Quinolinones compound and its applied in medicine |
WO2016045125A1 (en) * | 2014-09-28 | 2016-03-31 | Merck Sharp & Dohme Corp. | Inhibitors of hif prolyl hydroxylase |
CN104447547B (en) * | 2014-11-10 | 2017-04-19 | 苏州康润医药有限公司 | Synthesis method of 4-aminoisoquinoline-8-methyl formate |
CN106146490B (en) * | 2015-03-27 | 2018-10-23 | 沈阳三生制药有限责任公司 | 5- hydroxyl -1,7- naphthyridine compounds, preparation method and its pharmaceutical applications replaced by aryloxy group or heteroaryloxy |
CN104892509B (en) * | 2015-06-04 | 2018-03-09 | 苏州明锐医药科技有限公司 | Nuo get Si Ta preparation method |
CN106187888A (en) * | 2016-07-18 | 2016-12-07 | 江苏德源药业股份有限公司 | FG 4592 monocrystalline and preparation method thereof |
CN106478503A (en) * | 2016-09-29 | 2017-03-08 | 上海勋和医药科技有限公司 | The preparation method of Roxadustat intermediate |
CZ2016627A3 (en) | 2016-10-07 | 2018-04-18 | Zentiva, K.S. | A method of preparing (7-phenoxy-4-hydroxy-1-methyl-isoquinoline-3-carbonyl)glycine (roxadustate) and its intermediates based on the simultaneous opening of the oxazole ring, ether cleavage and imine formation |
CN107954931B (en) * | 2016-10-17 | 2021-06-22 | 上海医药集团青岛国风药业股份有限公司 | Preparation method of nodispat |
CN110225753B (en) | 2017-01-28 | 2022-12-09 | 金凯(辽宁)生命科技股份有限公司 | Process for preparing 5-phenoxy-1 (3H) isobenzofuranones |
CN111566090A (en) * | 2017-12-01 | 2020-08-21 | 雷迪博士实验室有限公司 | Preparation method of roxasistat and intermediate thereof |
CN109956870A (en) | 2017-12-14 | 2019-07-02 | 南京卡文迪许生物工程技术有限公司 | A kind of Luo Shasi his synthetic method and its midbody compound |
CN110218184B (en) * | 2018-03-01 | 2022-09-27 | 广东东阳光药业有限公司 | Nodesserts eutectic and preparation method thereof |
WO2019174631A1 (en) * | 2018-03-16 | 2019-09-19 | 上海医药集团股份有限公司 | Method for preparing norstat |
CN110526813B (en) * | 2018-05-24 | 2022-06-28 | 杭州科巢生物科技有限公司 | Process for producing isoquinoline compounds and intermediates thereof |
US11363815B2 (en) | 2018-06-05 | 2022-06-21 | Shenyang University Of Chemical Technology | Trifluoroethyl thioether (sulfoxide) substituted benzene compound and use thereof |
MX2021005314A (en) | 2018-11-09 | 2021-08-24 | Vivace Therapeutics Inc | Bicyclic compounds. |
CN109776415B (en) * | 2019-03-07 | 2020-11-17 | 福建南方制药股份有限公司 | Preparation method of Roxadustat intermediate |
WO2020214734A1 (en) | 2019-04-16 | 2020-10-22 | Vivace Therapeutics, Inc. | Bicyclic compounds |
RU2709493C1 (en) * | 2019-08-01 | 2019-12-18 | Марат Феликсович Фазылов | Method of producing roxadustat |
WO2021026307A1 (en) | 2019-08-07 | 2021-02-11 | Teva Pharmaceuticals International Gmbh | Processes for the preparation of roxadustat and intermediates thereof |
CN112441975B (en) * | 2019-09-03 | 2023-10-31 | 西藏嘉信景天药业有限公司 | Preparation method of important intermediate of roflumilast |
US20230112619A1 (en) * | 2019-10-18 | 2023-04-13 | Shanghai Desano Chemical Pharmaceutical Co., Ltd. | Method for preparing isoquinolinone compounds |
CN112679431B (en) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | Method for preparing isoquinolinones compound |
CN112679430B (en) * | 2019-10-18 | 2023-05-05 | 上海迪赛诺化学制药有限公司 | Method for preparing isoquinolinones compound |
CN113444042A (en) * | 2020-03-27 | 2021-09-28 | 南京海润医药有限公司 | Preparation method of Rosxastat |
CN115867537A (en) | 2020-04-21 | 2023-03-28 | 迈兰实验室有限公司 | Improved process for the preparation of a rasagiline base |
CN111533691A (en) * | 2020-06-08 | 2020-08-14 | 重庆三圣实业股份有限公司 | Preparation method of Rosxastat |
CN114539149A (en) * | 2020-06-19 | 2022-05-27 | 济川(上海)医学科技有限公司 | Compound containing isoquinoline ring, preparation method and application thereof |
CN112409258A (en) * | 2020-11-20 | 2021-02-26 | 杭州科巢生物科技有限公司 | Preparation method of Rosxastat |
CN114644589A (en) * | 2020-12-17 | 2022-06-21 | 鲁南制药集团股份有限公司 | Preparation method of compound N- [ (4-hydroxy-1-methyl-3-isoquinolyl) carbonyl ] -glycine |
US20230101768A1 (en) * | 2021-08-13 | 2023-03-30 | The Board Of Regents Of The University Of Texas System | Method to treat manganese toxicity and manganese-induced parkinsonism in humans |
CN115124467A (en) * | 2022-07-11 | 2022-09-30 | 天津力生制药股份有限公司 | Preparation method of key intermediate of roxasistat |
Family Cites Families (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4036964A (en) | 1973-10-11 | 1977-07-19 | Beecham Group Limited | Isocarbostyril-3-carboxylic acid derivatives for the prophylaxis of asthma, hayfever and rhinitis |
US3989704A (en) | 1973-10-30 | 1976-11-02 | Sandoz, Inc. | 3-Substituted-4-aryl isoquinolines |
DE2818423A1 (en) | 1978-04-27 | 1979-11-08 | Hoechst Ag | NEW ISOCHINOLINE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
DE3233424A1 (en) | 1982-09-09 | 1984-03-15 | Hoechst Ag, 6230 Frankfurt | ISOCHINOL DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS BASED ON THESE COMPOUNDS AND THEIR USE |
US4558006A (en) | 1983-02-04 | 1985-12-10 | Kirin-Amgen, Inc. | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin |
US4559403A (en) | 1983-05-19 | 1985-12-17 | Hoffmann-La Roche Inc. | Substituted isoquinolines |
US4584379A (en) | 1985-01-22 | 1986-04-22 | Merrell Dow Pharmaceuticals Inc. | Isoquinoline thromboxane synthetase inhibitors |
US4667016A (en) | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
US4822800A (en) | 1986-06-09 | 1989-04-18 | Ortho Pharmaceutical Corporation | Isoquinolinol compounds having cardiotonic and phosphodiesterase fraction III inhibiting properties and/or renal vasodilating properties |
US4966906A (en) | 1987-11-27 | 1990-10-30 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-isoquinolinecarboxamides |
US4952588A (en) | 1987-11-27 | 1990-08-28 | Hoechst-Roussel Pharmaceuticals Inc. | 1-aryl-3-quinoline-and 1-aryl-3-isoquinoline-carboxamides |
EP0650961B1 (en) | 1993-11-02 | 1997-03-05 | Hoechst Aktiengesellschaft | Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments |
DK0650960T3 (en) | 1993-11-02 | 1997-09-01 | Hoechst Ag | Substituted heterocyclic carboxylic acid amide esters, their preparation and their use as drugs. |
CA2138929A1 (en) | 1993-12-30 | 1995-07-01 | Klaus Weidmann | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
AU4515696A (en) | 1994-12-12 | 1996-07-03 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
IL135495A (en) | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of substituted quinoline-2-carboxylic acid amides |
JP2001527527A (en) | 1996-11-27 | 2001-12-25 | デュポン ファーマシューティカルズ カンパニー | Novel integrin receptor antagonist |
DE19746287A1 (en) | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituted isoquinoline-2-carboxylic acid amides, their preparation and their use as medicaments |
FR2779963A1 (en) | 1998-06-22 | 1999-12-24 | Centre Nat Rech Scient | New composition useful for treat cancer, comprises compound with affinity for mitochondrial benzodiazepine receptors and agent to induce apoptosis |
IT1302677B1 (en) | 1998-10-15 | 2000-09-29 | Zambon Spa | BENZAZINIC DERIVATIVES INHIBITORS OF PHOSPHODIESTERASE 4 |
AU4802500A (en) | 1999-04-26 | 2000-11-10 | Neurogen Corporation | 2-aminoquinolinecarboxamides: neurokinin receptor ligands |
IT1320162B1 (en) | 2000-02-09 | 2003-11-18 | Rotta Research Lab | DERIVATIVES OF THYROSIN WITH ANTI LEUKOTRIENIC ACTIVITY, PROCEDURES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL USE. |
FI20002044A0 (en) | 2000-09-15 | 2000-09-15 | Orion Yhtymae Oyj | Naphthalene derivatives which inhibit Comt enzymes |
DE10110750A1 (en) | 2001-03-07 | 2002-09-12 | Bayer Ag | Novel aminodicarboxylic acid derivatives with pharmaceutical properties |
US6855510B2 (en) | 2001-03-20 | 2005-02-15 | Dana Farber Cancer Institute, Inc. | Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
WO2002074981A2 (en) | 2001-03-21 | 2002-09-26 | Isis Innovation Ltd. | Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
JP2005505507A (en) | 2001-06-13 | 2005-02-24 | ジーンソフト ファーマシューティカルズ インコーポレイテッド | Isoquinoline compounds having anti-infective activity |
WO2002101073A2 (en) | 2001-06-13 | 2002-12-19 | Genesoft Pharmaceuticals, Inc. | Aryl-benzimidazole compounds having antiinfective activity |
US6762318B2 (en) | 2001-12-03 | 2004-07-13 | Novo Nordisk A/S | Glucagon antagonists |
US20030153503A1 (en) | 2001-12-06 | 2003-08-14 | Klaus Stephen J. | Methods of increasing endogenous erythropoietin (EPO) |
US8318703B2 (en) | 2001-12-06 | 2012-11-27 | Fibrogen, Inc. | Methods for improving kidney function |
US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
GB0229581D0 (en) * | 2002-12-19 | 2003-01-22 | Cyclacel Ltd | Use |
WO2005007192A2 (en) | 2003-06-06 | 2005-01-27 | Fibrogen, Inc. | Cytoprotection through the use of hif hydroxylase inhibitors |
CN102977015B (en) * | 2003-06-06 | 2015-05-06 | 菲布罗根有限公司 | Nitrogen-containing heteroaryl compounds and their use in increasing endogeneous erythropoietin |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
CA2532064A1 (en) | 2003-07-15 | 2005-02-03 | Merck & Co., Inc. | Hydroxypyridine cgrp receptor antagonists |
EP1658074B1 (en) | 2003-08-01 | 2012-11-07 | Fibrogen, Inc. | Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
JP2007501844A (en) | 2003-08-08 | 2007-02-01 | トランス テック ファーマ,インコーポレイテッド | Aryl and heteroaryl compounds, compositions and methods of use |
US7208601B2 (en) | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
DE602005016800D1 (en) | 2004-05-28 | 2009-11-05 | Fibrogen Inc | HIF-prolyl hydroxylase ACTIVITY TEST |
AP2007004047A0 (en) * | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
JP4792048B2 (en) | 2005-03-02 | 2011-10-12 | ファイブロゲン インコーポレイティッド | Thienopyridine compounds and methods of use thereof |
US20060276477A1 (en) | 2005-06-06 | 2006-12-07 | Fibrogen, Inc. | Treatment method for anemia |
KR20080028918A (en) | 2005-06-15 | 2008-04-02 | 피브로겐, 인크. | Compounds and methods for treatment of cancer |
US7707178B2 (en) | 2005-11-28 | 2010-04-27 | Commvault Systems, Inc. | Systems and methods for classifying and transferring information in a storage network |
CN103382216B (en) | 2006-01-27 | 2016-04-20 | 菲布罗根有限公司 | Make the Cyanoisoquinoline compound that hypoxia inducible factor (HIF) is stable |
CN101420980A (en) | 2006-02-16 | 2009-04-29 | 菲布罗根公司 | The Compounds and methods for of treatment apoplexy |
CA2647596C (en) | 2006-04-04 | 2012-06-12 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as hif modulators |
US7713986B2 (en) | 2006-06-15 | 2010-05-11 | Fibrogen, Inc. | Compounds and methods for treatment of chemotherapy-induced anemia |
US20070293575A1 (en) | 2006-06-15 | 2007-12-20 | Fibrogen, Inc. | Compounds and methods for treatment of cancer-related anemia |
WO2009073669A1 (en) | 2007-12-03 | 2009-06-11 | Fibrogen, Inc. | Isoxazolopyridine derivatives for use in the treatment of hif-mediated conditions |
US8952160B2 (en) | 2008-01-11 | 2015-02-10 | Fibrogen, Inc. | Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity |
US8324405B2 (en) | 2008-02-05 | 2012-12-04 | Fibrogen, Inc. | Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors |
EP2334682B1 (en) | 2008-08-20 | 2017-10-04 | Fibrogen, Inc. | Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators |
WO2010056767A1 (en) | 2008-11-14 | 2010-05-20 | Fibrogen, Inc. | Thiochromene derivatives as hip hydroxylase inhibitors |
US20140171465A1 (en) | 2011-01-13 | 2014-06-19 | Fibrogen, Inc. | Methods For Increasing Reticulocyte Hemoglobin Content |
WO2012106472A1 (en) | 2011-02-02 | 2012-08-09 | Fibrogen, Inc. | Naphthyridine derivatives as inhibitors of hypoxia inducible factor (hif) hydroxylase |
US9206134B2 (en) * | 2011-07-22 | 2015-12-08 | Beijing Betta Pharmaceuticals Co. Ltd. | Polymorphic forms of compounds as prolyl hydroxylase inhibitor, and uses thereof |
EP2834220B1 (en) | 2012-03-09 | 2016-11-09 | Fibrogen, Inc. | 4-hydroxy-isoquinoline compounds as hif hydroxylase inhibitors |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
CN107540607A (en) | 2012-07-16 | 2018-01-05 | 菲布罗根有限公司 | The crystal habit of prolyl hydroxylase inhibitors |
MY171483A (en) * | 2012-07-16 | 2019-10-15 | Fibrogen Inc | Process for making isoquinoline compounds |
RU2666144C2 (en) | 2013-01-24 | 2018-09-06 | Фиброген, Инк. | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid |
KR20220164069A (en) | 2013-06-06 | 2022-12-12 | 피브로겐, 인크. | Pharmaceutical formulations of a hif hydroxylase inhibitor |
-
2013
- 2013-07-15 MY MYPI2015000128A patent/MY171483A/en unknown
- 2013-07-15 CN CN201310302822.0A patent/CN103435546B/en active Active
- 2013-07-15 CN CN201610421229.1A patent/CN106083719B/en active Active
- 2013-07-15 BR BR112015001106-3A patent/BR112015001106B1/en active IP Right Grant
- 2013-07-15 CA CA2879238A patent/CA2879238C/en active Active
- 2013-07-15 ES ES13740184.0T patent/ES2631655T3/en active Active
- 2013-07-15 US US14/414,879 patent/US9340511B2/en active Active
- 2013-07-15 SG SG11201500234YA patent/SG11201500234YA/en unknown
- 2013-07-15 EP EP17155678.0A patent/EP3219706A1/en not_active Withdrawn
- 2013-07-15 PL PL13740184T patent/PL2872487T3/en unknown
- 2013-07-15 NZ NZ704660A patent/NZ704660A/en unknown
- 2013-07-15 JP JP2015523159A patent/JP6196671B2/en active Active
- 2013-07-15 HU HUE13740184A patent/HUE034409T2/en unknown
- 2013-07-15 KR KR1020157003197A patent/KR102145272B1/en active Protection Beyond IP Right Term
- 2013-07-15 WO PCT/US2013/050538 patent/WO2014014834A1/en active Application Filing
- 2013-07-15 PT PT137401840T patent/PT2872487T/en unknown
- 2013-07-15 IN IN265KON2015 patent/IN2015KN00265A/en unknown
- 2013-07-15 DK DK13740184.0T patent/DK2872487T3/en active
- 2013-07-15 AU AU2013290437A patent/AU2013290437B2/en active Active
- 2013-07-15 EP EP13740184.0A patent/EP2872487B1/en active Active
- 2013-07-15 MX MX2015000505A patent/MX350922B/en active IP Right Grant
-
2015
- 2015-01-11 IL IL236625A patent/IL236625B/en active IP Right Grant
- 2015-01-29 ZA ZA2015/00664A patent/ZA201500664B/en unknown
-
2016
- 2016-03-17 US US15/073,251 patent/US9708269B2/en active Active
-
2022
- 2022-06-16 HU HUS2200030C patent/HUS2200030I1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201500664B (en) | Process for making isoquinoline compounds | |
EP2890672A4 (en) | New process | |
GB201216921D0 (en) | Process | |
HK1244272A1 (en) | Process for making thienopyrimidine compounds | |
GB201207997D0 (en) | Process | |
HK1208673A1 (en) | Process for making hydroxylated cyclopentylpyrimidine compounds | |
HK1208451A1 (en) | Process for making hydroxylated cyclopentylpyrimidine compounds | |
ZA201408399B (en) | Hydroformylation process | |
GB201214326D0 (en) | Process | |
GB201213360D0 (en) | Process | |
EP2852660A4 (en) | Process | |
PT2914574T (en) | New process | |
EP2855433A4 (en) | Process for preparing dihalopyridines | |
EP2819995A4 (en) | Process for preparing 3-methylsulfonylpropionitrile | |
GB201219224D0 (en) | Process | |
GB201219960D0 (en) | Process | |
IL233433A (en) | Process for making amides | |
GB201218078D0 (en) | Process | |
HUP1200614A2 (en) | Process for development catalayzer | |
GB201216653D0 (en) | Process | |
GB201220666D0 (en) | Process for preparing chemical compounds | |
GB201209932D0 (en) | Improved process | |
GB201220746D0 (en) | Process | |
GB201202098D0 (en) | New process | |
GB201220610D0 (en) | Process |